About FDA
Percentage of new or reformulated infant formula notification reviews completed during the month within 90 days of filing
Dictionary: Timely review of notifications for new and reformulated infant formulas is essential for protecting the health and well being of infants. Since these statutory requirements are notifications rather than pre-market approvals, it is essential that ONLDS have completed review of the information before the submitter markets the product, to notify them of any safety or regulatory concerns before the product reaches consumers.
Information is current as of December 31, 2012.
Fiscal Year - 2013
| Time | Annual Target | Percentage |
|---|---|---|
| Oct 2012 | 90 | 100 |
| Nov 2012 | 90 | 100 |
| Dec 2012 | 90 | 100 |
| Jan 2013 | 90 | TBD |
| Feb 2013 | 90 | TBD |
| Mar 2013 | 90 | TBD |
| Apr 2013 | 90 | TBD |
| May 2013 | 90 | TBD |
| Jun 2013 | 90 | TBD |
| Jul 2013 | 90 | TBD |
| Aug 2013 | 90 | TBD |
| Sep 2013 | 90 | TBD |
FY 2013 YTD: 100%
Number of new or reformulated infant formula notification reviews due to be completed during the month
Fiscal Year - 2013
| Time | Annual Target | Number |
|---|---|---|
| Oct 2012 | N/A | 2 |
| Nov 2012 | N/A | 3 |
| Dec 2012 | N/A | 4 |
| Jan 2013 | N/A | TBD |
| Feb 2013 | N/A | TBD |
| Mar 2013 | N/A | TBD |
| Apr 2013 | N/A | TBD |
| May 2013 | N/A | TBD |
| Jun 2013 | N/A | TBD |
| Jul 2013 | N/A | TBD |
| Aug 2013 | N/A | TBD |
| Sep 2013 | N/A | TBD |
FY 2013 YTD: 9
Number of infant formula notification reviews completed during the month within 90 days of filing
Fiscal Year - 2013
| Time | Annual Target | Number |
|---|---|---|
| Oct 2012 | N/A | 2 |
| Nov 2012 | N/A | 3 |
| Dec 2012 | N/A | 4 |
| Jan 2013 | N/A | TBD |
| Feb 2013 | N/A | TBD |
| Mar 2013 | N/A | TBD |
| Apr 2013 | N/A | TBD |
| May 2013 | N/A | TBD |
| Jun 2013 | N/A | TBD |
| Jul 2013 | N/A | TBD |
| Aug 2013 | N/A | TBD |
| Sep 2013 | N/A | TBD |
FY 2013 YTD: 9
Total number of infant formula notification reviews completed during the month
Fiscal Year - 2013
| Time | Annual Target | Number |
|---|---|---|
| Oct 2012 | N/A | 2 |
| Nov 2012 | N/A | 3 |
| Dec 2012 | N/A | 4 |
| Jan 2013 | N/A | TBD |
| Feb 2013 | N/A | TBD |
| Mar 2013 | N/A | TBD |
| Apr 2013 | N/A | TBD |
| May 2013 | N/A | TBD |
| Jun 2013 | N/A | TBD |
| Jul 2013 | N/A | TBD |
| Aug 2013 | N/A | TBD |
| Sep 2013 | N/A | TBD |
FY 2013 YTD: 9
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
